A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies

Name: A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies
Published: 2022
License: Public Domain

Xencor, Inc. · 2022

ClinicalTrials.gov · Datasets · License: Public Domain · 2022

Open Source ↗

cervical-cancer ovarian-cancer prostate-cancer

ovarian cancer, clear cell carcinoma, endometrial cancer, cervical carcinoma, metastatic castration-resistant prostate cancer (mcrpc), cervical cancer, prostate cancer, gynecological cancer,, fallopian tube cancer, peritoneal cancer, vudalimab, xmab20717

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 804957
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.